PULSE BIOSCIENCES, INC. 8-K

What Happened
Pulse Biosciences, Inc. announced financial and operational results for the fiscal quarter and full year ended December 31, 2025. The announcement was made on February 19, 2026 and the company attached a press release (Exhibit 99.1) summarizing the business update and financial results. The information is furnished under Item 2.02 of Form 8-K.

Key Details

• Announcement date: February 19, 2026.
• Reporting periods: fiscal quarter and full year ended December 31, 2025.
• Exhibit attached: Press Release (Exhibit 99.1) titled "Business Update and Financial Results."
• Filing status: the information and Exhibit 99.1 are furnished (not “filed”) under the Exchange Act; also included cover page interactive XBRL (Exhibit 104).

Why It Matters
This 8-K lets investors know Pulse has released its latest quarterly and full‑year financial results and operational update — the press release will contain the detailed revenue, earnings, cash flow, and any business developments or guidance changes that can affect the stock. Because the release is furnished (not filed), it is subject to different disclosure liabilities and is not automatically incorporated by reference into other SEC filings. Retail investors should read the attached press release for the specific figures and operational details and watch for any subsequent filed reports (e.g., 10-K or 10-Q) that formally present audited or detailed financials.